Infectious complications of biologic therapeutics
نویسندگان
چکیده
منابع مشابه
Infectious Complications With the Use of Biologic Response Modifiers in Infants and Children.
Biologic response modifiers (BRMs) are substances that interact with and modify the host immune system. BRMs that dampen the immune system are used to treat conditions such as juvenile idiopathic arthritis, psoriatic arthritis, or inflammatory bowel disease and often in combination with other immunosuppressive agents, such as methotrexate and corticosteroids. Cytokines that are targeted include...
متن کاملSafety profile of IBD therapeutics: infectious risks.
Over the last decade, the medical treatment of inflammatory bowel disease (IBD) has been revolutionized, with increasing use of both immunomodulatory and biologic medications. Corticosteroids have increasingly been shown to increase the risk of serious and opportunistic infections, both independently and in combination with immunomodulator and biologic agents. There are limited data on the infe...
متن کاملEnhancing Endosomal Escape for Intracellular Delivery of Macromolecular Biologic Therapeutics
Bioactive macromolecular peptides and oligonucleotides have significant therapeutic potential. However, due to their size, they have no ability to enter the cytoplasm of cells. Peptide/Protein transduction domains (PTDs), also called cell-penetrating peptides (CPPs), can promote uptake of macromolecules via endocytosis. However, overcoming the rate-limiting step of endosomal escape into the cyt...
متن کاملAre we ready for therapeutic drug monitoring of biologic therapeutics?
In the previous issue of Arthritis Research & Therapy, Ducourau and colleagues report that they retrospectively detected anti-infliximab antibodies in 21% of patients with rheumatic diseases. Patients with anti-infliximab antibodies had lower serum drug concentrations. These findings contribute to the existing evidence of immunogenicity of biologicals and its clinical relevance. We argue for th...
متن کاملInfectious Complications in Hematology
Post-induction aplasia for acute myeloid leukemia (AML)/myelodysplastic syndromes (MDS) is a period at highrisk for invasive fungal disease (IFD). Invasive aspergillosis (IA) remains the commonest cause of IFD and crude mortality remains considerable at 33-47%. For patients surviving IFDs, delays or modifications to curative chemotherapy may compromise long-term prognosis. Poor clinical outcome...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Infectious Diseases
سال: 2016
ISSN: 1201-9712
DOI: 10.1016/j.ijid.2016.02.153